BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38484700)

  • 1. Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042).
    Hwang WY; Choi CH; Kim K; Kim MH; Lim MC; Lee B; Kim M; Kim YH; Seong SJ; Lee JM
    Obstet Gynecol Sci; 2024 May; 67(3):296-303. PubMed ID: 38484700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Conization and Risk of Recurrence in Patients Undergoing Laparoscopic Radical Hysterectomy for Early Stage Cervical Cancer: A Multicenter Study.
    Casarin J; Bogani G; Papadia A; Ditto A; Pinelli C; Garzon S; Donadello N; Laganà AS; Cromi A; Mueller M; Raspagliesi F; Ghezzi F
    J Minim Invasive Gynecol; 2021 Jan; 28(1):117-123. PubMed ID: 32320800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
    Bizzarri N; Querleu D; Dostálek L; van Lonkhuijzen LRCW; Giannarelli D; Lopez A; Salehi S; Ayhan A; Kim SH; Ortiz DI; Klat J; Landoni F; Pareja R; Manchanda R; Kosťun J; Ramirez PT; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Dos Reis R; Pedone Anchora L; Amaro K; Akilli H; Abu-Rustum NR; Salcedo-Hernández RA; Javůrková V; Mom CH; Scambia G; Falconer H; Cibula D
    Am J Obstet Gynecol; 2023 Oct; 229(4):428.e1-428.e12. PubMed ID: 37336255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
    Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
    Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.
    Chen X; Zhao N; Ye P; Chen J; Nan X; Zhao H; Zhou K; Zhang Y; Xue J; Zhou H; Shang H; Zhu H; Leanne VM; Yan X
    Int J Gynecol Cancer; 2020 May; 30(5):564-571. PubMed ID: 32276941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 9. Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
    Haesen J; Salihi R; Van Gorp T; Van Nieuwenhuysen E; Han SN; Christiaens M; Van Rompuy AS; Waumans L; Neven P; Vergote I
    Gynecol Oncol; 2021 Sep; 162(3):539-545. PubMed ID: 34253389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
    Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
    Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
    He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
    Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer.
    Sakuragi N; Kato T; Shimada C; Kaneuchi M; Todo Y; Mitamura T; Takeda M; Kudo M; Murakami G; Watari H
    JAMA Netw Open; 2020 May; 3(5):e204307. PubMed ID: 32379332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic ovarian transposition in patients with early cervical cancer.
    Pahisa J; Martínez-Román S; Martínez-Zamora MA; Torné A; Caparrós X; Sanjuán A; Lejárcegui JA
    Int J Gynecol Cancer; 2008; 18(3):584-9. PubMed ID: 18476952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
    Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between location of transposed ovary and function in cervical cancer patients who underwent radical hysterectomy.
    Yoon A; Lee YY; Park W; Huh SJ; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
    Int J Gynecol Cancer; 2015 May; 25(4):688-93. PubMed ID: 25675036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-sparing surgery of cervical cancer >2 cm (International Federation of Gynecology and Obstetrics 2009 stage IB1-IIA) after neoadjuvant chemotherapy.
    Tesfai FM; Kroep JR; Gaarenstroom K; De Kroon C; Van Loenhout R; Smit V; Trimbos B; Nout RA; van Poelgeest MIE; Beltman JJ
    Int J Gynecol Cancer; 2020 Jan; 30(1):115-121. PubMed ID: 31744889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored radical hysterectomy for locally advanced cervical cancer.
    Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
    Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the pathologic tumor size associated with survival in early cervical cancer treated with radical hysterectomy and adjuvant radiotherapy?
    Cho WK; Park W; Kim H; Kim YJ; Kim YS
    Taiwan J Obstet Gynecol; 2022 Mar; 61(2):329-332. PubMed ID: 35361396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
    Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.